Life Sciences’ Shifting Sands: 5 Trends that Threaten the Status Quo
Change is the only constant in the new normal, something that applies as much to life sciences now as to other markets more readily associated with disruption, such as retail and banking. But the pharmaceutical industry is not known for its adaptability, so how will it weather the choppy conditions currently characterising the market – and can technology ease the strain?